Beam Therapeutics Inc.
Total Trades
71
Buys
0
Sells
56
Largest Trade
N/A
Insiders
8
Institutional Funds
191
Inst. Value
$1M+
Activist Filings
38
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Evans John M. | CEO | EXERCISE | $15K–$50K | 50K | $0.67 | Feb 2, 2026 |
| Evans John M. | CEO | SELL | $1M+ | 50K | $28.87 | Feb 2, 2026 |
| Cavanagh Bethany J | SVP | SELL | $100K–$500K | 6K | $35.00 | Jan 26, 2026 |
| Bellon Christine | Chief Legal Officer | SELL | $15K–$50K | 1K | $34.00 | Jan 26, 2026 |
| Cavanagh Bethany J | SVP | SELL | $50K–$100K | 3K | $30.12 | Jan 21, 2026 |
| Bellon Christine | Chief Legal Officer | SELL | $500K+ | 19K | $34.61 | Jan 20, 2026 |
| Emany Sravan Kumar | CFO | SELL | $100K–$500K | 6K | $27.10 | Jan 5, 2026 |
| Bellon Christine | Chief Legal Officer | SELL | $15K–$50K | 1K | $27.10 | Jan 5, 2026 |
| FMR LLC | 10% Owner | SELL | $1K–$15K | 459 | $26.68 | Oct 29, 2025 |
| FMR LLC | 10% Owner | SELL | $500K+ | 48K | $20.50 | Aug 1, 2025 |
| Simon Amy | Chief Medical Offi… | SELL | $15K–$50K | 1K | $19.17 | Jul 3, 2025 |
| Bellon Christine | Chief Legal Officer | SELL | $100K–$500K | 6K | $18.35 | Apr 4, 2025 |
| Evans John M. | CEO | SELL | $500K+ | 31K | $18.35 | Apr 4, 2025 |
| Ciaramella Giuseppe | President | SELL | $100K–$500K | 7K | $18.35 | Apr 4, 2025 |
| Cavanagh Bethany J | SVP | SELL | $50K–$100K | 3K | $18.35 | Apr 4, 2025 |
| Simon Amy | Chief Medical Offi… | SELL | $500K+ | 31K | $17.92 | Apr 4, 2025 |
| Bellon Christine | Chief Legal Officer | SELL | $15K–$50K | 1K | $24.68 | Jan 6, 2025 |
| Cavanagh Bethany J | SVP | SELL | $15K–$50K | 1K | $24.68 | Jan 6, 2025 |
| Ciaramella Giuseppe | President | SELL | $1M+ | 51K | $26.36 | Nov 8, 2024 |
| Ciaramella Giuseppe | President | SELL | $1M+ | 51K | $26.27 | Oct 16, 2024 |
| Ciaramella Giuseppe | President | EXERCISE | $50K–$100K | 42K | $2.00 | Oct 16, 2024 |
| Bellon Christine | Chief Legal Officer | SELL | $1K–$15K | 385 | $23.48 | Oct 2, 2024 |
| Cavanagh Bethany J | SVP | SELL | $1K–$15K | 289 | $23.48 | Oct 2, 2024 |
| Cavanagh Bethany J | SVP | GRANT | N/A | 3K | — | Oct 2, 2024 |
| Evans John M. | CEO | SELL | $1M+ | 60K | $24.60 | Oct 2, 2024 |
| Simon Amy | Chief Medical Offi… | SELL | $15K–$50K | 1K | $23.28 | Jul 3, 2024 |
| Evans John M. | CEO | SELL | $1M+ | 60K | $24.50 | Jun 28, 2024 |
| Simon Amy | Chief Medical Offi… | SELL | $500K+ | 24K | $31.02 | Apr 3, 2024 |
| Bellon Christine | Chief Legal Officer | SELL | $100K–$500K | 3K | $32.12 | Apr 3, 2024 |
| Burrell Terry-Ann | CFO | SELL | $100K–$500K | 5K | $32.12 | Apr 3, 2024 |
| Evans John M. | CEO | SELL | $500K+ | 18K | $32.13 | Apr 3, 2024 |
| Ciaramella Giuseppe | President | SELL | $100K–$500K | 5K | $32.12 | Apr 3, 2024 |
| Evans John M. | CEO | GRANT | N/A | 78K | — | Apr 1, 2024 |
| Evans John M. | CEO | SELL | $1M+ | 60K | $33.86 | Apr 1, 2024 |
| FMR LLC | Insider | SELL | $1M+ | 902K | $30.55 | Feb 15, 2024 |
| Evans John M. | CEO | SELL | $1M+ | 60K | $25.33 | Feb 2, 2024 |
| Bellon Christine | Chief Legal Officer | SELL | $100K–$500K | 10K | $30.50 | Nov 22, 2023 |
| Bellon Christine | Chief Legal Officer | EXERCISE | $50K–$100K | 10K | $7.22 | Nov 22, 2023 |
| Simon Amy | Chief Medical Offi… | SELL | $50K–$100K | 3K | $18.70 | Nov 1, 2023 |
| Bellon Christine | Chief Legal Officer | SELL | $1K–$15K | 388 | $22.85 | Oct 4, 2023 |
| Simon Amy | Chief Medical Offi… | SELL | $1K–$15K | 391 | $30.48 | Aug 9, 2023 |
| Ciaramella Giuseppe | President and CSO | EXERCISE | $500K+ | 92K | $7.22 | Jul 25, 2023 |
| Ciaramella Giuseppe | President and CSO | SELL | $1M+ | 157K | $32.06 | Jul 25, 2023 |
| Evans John M. | CEO | SELL | $100K–$500K | 12K | $29.63 | Apr 6, 2023 |
| Ciaramella Giuseppe | President & CSO | SELL | $100K–$500K | 4K | $29.73 | Apr 6, 2023 |
| Bellon Christine | Chief Legal Officer | SELL | $50K–$100K | 2K | $29.63 | Apr 6, 2023 |
| Simon Amy | Chief Medical Offi… | SELL | $100K–$500K | 16K | $29.87 | Apr 6, 2023 |
| Burrell Terry-Ann | CFO | SELL | $100K–$500K | 5K | $29.74 | Apr 6, 2023 |
| Burrell Terry-Ann | CFO | SELL | $1M+ | 37K | $45.08 | Jan 30, 2023 |
| Burrell Terry-Ann | CFO | EXERCISE | $500K+ | 37K | $13.68 | Jan 30, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 191 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ARK Investment Management LLC | 12.5M | $1M+ | SH |
| STATE STREET CORP | 5.2M | $1M+ | SH |
| Sumitomo Mitsui Trust Group, Inc. | 4.4M | $1M+ | SH |
| Amova Asset Management Americas, Inc. | 4.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.8M | $1M+ | SH |
| Redmile Group, LLC | 1.3M | $1M+ | SH |
| MARSHALL WACE, LLP | 946K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 835K | $1M+ | SH |
| VANGUARD GROUP INC | 670K | $1M+ | SH |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 534K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 492K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 469K | $1M+ | SH |
| Pictet Asset Management Holding SA | 326K | $1M+ | SH |
| BARCLAYS PLC | 326K | $1M+ | SH |
| Alphabet Inc. | 322K | $1M+ | SH |
| PEREGRINE INVESTMENT MANAGEMENT INC | 257K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 256K | $1M+ | SH |
| Vestmark Advisory Solutions, Inc. | 196K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 191K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 9, 2026
5.2%
5.2M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 5, 2026
0.7%
689K shares
SC 13G/A · Feb 5, 2026
12.6%
12.8M shares
SC 13G/A · Feb 3, 2026
12.3%
12.5M shares
SC 13G/A · Nov 5, 2025
13.6%
13.8M shares
SC 13G/A · Aug 7, 2025
10.3%
10.4M shares
SC 13G/A · Aug 6, 2025
15.0%
15.1M shares
SC 13G/A · May 15, 2025
4.5%
4.5M shares
Farallon Capital Partners, L.P.
SC 13G/A · May 13, 2025
0.7%
708K shares
SC 13G/A · Apr 17, 2025
7.5%
7.5M shares
SC 13G/A · Apr 2, 2025
10.1%
10.0M shares
SC 13G/A · Feb 14, 2025
5.5%
4.5M shares
SC 13G/A · Feb 12, 2025
6.6%
5.4M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 6, 2025
0.7%
574K shares
SC 13G/A · Jan 11, 2025
7.9%
6.5M shares
SC 13G/A · Nov 12, 2024
7.8%
6.4M shares
SC 13G/A · Nov 8, 2024
9.4%
7.7M shares
Farallon Capital Partners, L.P.
SC 13G/A · Nov 7, 2024
0.7%
574K shares
SC 13G/A · Oct 21, 2024
9.4%
7.7M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 17, 2024
4.8%
3.9M shares
(S) ARCH Venture Fund IX, L.P.
SC 13G/A · Feb 14, 2024
6.7%
5.4M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.8%
7.2M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 12, 2024
0.7%
542K shares
SC 13G/A · Jan 29, 2024
11.5%
9.4M shares
SC 13G/A · Jan 25, 2024
8.2%
6.7M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Jan 24, 2024
5.7%
0 shares
Farallon Capital Partners, L.P.
SC 13G · Sep 22, 2023
0.4%
307K shares
Temasek Holdings (Private) Limited
SC 13G · Mar 17, 2023
5.0%
3.6M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 10, 2023
11.7%
8.2M shares
Temasek Holdings (Private) Limited
SC 13G/A · Feb 10, 2023
4.1%
2.9M shares
SC 13G/A · Feb 2, 2023
7.4%
5.2M shares
Farallon Capital Partners, L.P.
SC 13G · Jul 14, 2022
0.4%
277K shares
SC 13G/A · Feb 14, 2022
2.8%
1.9M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
(S) ARCH Venture Fund IX, L.P.
SC 13G/A · Feb 14, 2022
8.6%
5.8M shares
Temasek Holdings (Private) Limited
SC 13G/A · Feb 14, 2022
5.8%
4.0M shares
SC 13G/A · Jan 24, 2022
10.0%
6.8M shares